Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLOG
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
How integrated data systems enhance clinical development and manufacturing
Published by PharmaVoice In the rapidly evolving landscape of biopharmaceuticals, the integration of robust digital systems has become paramount....
.png)
CDMOs Are Making Their Supply Chains More Resilient & Secure
Published byDrug Development & Delivery Growing R&D activities, personalized medicines, large-scale production of biologics, and access to new...
